Using clinical E. coli bacteremia isolates—bacteria from the blood of patients—Conlon, first author Joshua Parsons, MD, Ph.D., an infectious diseases fellow at Duke University, and colleagues ...
"The publication of the Chinese subpopulation data from the NEFECON® global Phase 3 NefIgArd clinical trial in the 'Kidney 360' magazine further supports the clinical evidence of NEFECON® in the ...